A carregar...
Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer
Pancreatic cancer is highly malignant with limited therapy and a poor prognosis. TRAIL-activating therapy has been promising, however, clinical trials have shown resistance and limited responses of pancreatic cancers. We investigated the effects of calmodulin(CaM) antagonists, trifluoperazine(TFP) a...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4694833/ https://ncbi.nlm.nih.gov/pubmed/26320171 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|